MetaADEDB 2.0 @ LMMD
Crystamine
(ILZDURAAGGSKOQ-WZHZPDAFSA-L)
Structure
SMILES
OC[C@H]1O[C@@H]([C@@H]([C@@H]1OP(=O)(O[C@@H](CNC(=O)CC[C@@]1(C)/C/2=C(\C)/C3=N/C(=C\C4=N/C(=C(\C5=N[C@]([C@@H]([C@@H]1CC(=O)N)[N-]2)(C)[C@@](C)(CC(=O)N)[C@@H]5CCC(=O)N)/C)/[C@@]([C@@H]4CCC(=O)N)(C)CC(=O)N)/C([C@@H]3CCC(=O)N)(C)C)C)[O-])O)n1cnc2c1cc(C)c(c2)C.[C-]#N.[Co]
Molecular Formula:
C63H88CoN14O14P---
Molecular Weight:
1355.370
Log P:
6.7119
Hydrogen Bond Acceptor:
27
Hydrogen Bond Donor:
9
TPSA:
484.42
CAS Number(s):
68-19-9
Synonym(s)
1.
Crystamine
External Link(s)
PubChem Compound70678590
ChEBI17439
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AnxietyFAERS: 1US FAERS
2Application site massFAERS: 1US FAERS
3Blood cholesterol increasedFAERS: 1US FAERS
4Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
5Chest discomfortFAERS: 1US FAERS
6FlushingFAERS: 1US FAERS
7HypothyroidismFAERS: 1US FAERS
8Incorrect drug administration durationFAERS: 1US FAERS
9LethargyFAERS: 1US FAERS
10MalaiseFAERS: 1US FAERS
11MyalgiaFAERS: 1US FAERS
12NauseaFAERS: 1US FAERS
13Neck PainFAERS: 1US FAERS
14PresyncopeFAERS: 1US FAERS
15VomitingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.